Trial Profile
An open label pilot study of combined treatment of intravenous cyclophosphamide and thalidomide in refractory Crohn's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Cyclophosphamide (Primary) ; Thalidomide (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 13 Dec 2015 New trial record